Last reviewed · How we verify

NCT06086236

Vagus Nerve Stimulation Effects on Autonomic Nervous System Activity

Completed NA Last updated 17 October 2023
What this trial tests

NA trial testing Transcutaneous Auricular Vagus Nerve Stimulation in Vagus Nerve Stimulation in 72 participants. Completed in 10 September 2023.

Timeline
1 April 2023
Primary endpoint
1 September 2023
10 September 2023

Quick facts

Lead sponsorBahçeşehir University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment72
Start date1 April 2023
Primary completion1 September 2023
Estimated completion10 September 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bahçeşehir University

Who can join

Adults 18 to 40, any sex, with Vagus Nerve Stimulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transcutaneous Auricular Vagus nerve stimulation may be successful in cardiac modulation because of the cardiac connections of the vagal nerve. Therefore, in order to observe the cardiac effects, it was analysed the changes in pulse rate, systolic and diastolic blood pressure after transcutaneous auricular vagus nerve stimulation application.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcutaneous Auricular Vagus Nerve Stimulation

Trials testing the same drug.

Other recruiting trials for Vagus Nerve Stimulation

Currently open trials in the same condition.

Other Bahçeşehir University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06086236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing